UPCOMING SESSIONS in ET
Thu, Sep 3, 2026
5:00 – 6:00 AM Bangkok
How I treat AL Amyloidosis: Emerging Therapies Angela Dispenzieri Click Here To Register
UPCOMING SESSIONS in ET
Thu, Sep 3, 2026 · 5:00 – 6:00 AM Bangkok
How I treat AL Amyloidosis: Emerging Therapies
Angela Dispenzieri
Click Here To Register
View all sessions
Patients with systemic amyloidosis should be considered at increased risk of complications and mortality in case of SARS-CoV2 infection. This may be particularly…
Background: Technetium pyrophosphate (99mTc-PYP) imaging to diagnose transthyretin cardiac amyloidosis (ATTR-CA) has been increasingly utilized. The objective of…
Systemic AL amyloidosis is a plasma cell dyscrasia with a characteristic clinical phenotype caused by multi-organ deposition of an amyloidogenic monoclonal protein…